Schedule 13G ownership disclosure
PASITHEA THERAPEUTICS CORP
Security class unavailable · CUSIP: 70261F103
Event date: 2022-10-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 34,086,961
- Percent of class
- 11.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-23-003780
- Form type
- SC 13G
- Filer
- Manning Paul B
- CIK
- CIK 1494695
- Filed
- Feb 15, 2023
- Reporting period
- Oct 22, 2022
- Description
- Schedule 13G beneficial ownership